US Stock MarketDetailed Quotes

ONCT Oncternal Therapeutics

Watchlist
  • 0.5266
  • 0.00000.00%
Close Dec 2 16:00 ET
1.56MMarket Cap-0.05P/E (TTM)

Oncternal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-16.45%8.68M
-7.15%8.86M
-27.70%8.78M
-7.19%41.71M
-19.13%9.64M
-8.26%10.39M
-19.08%9.55M
22.51%12.14M
43.30%44.95M
47.46%11.92M
Selling and administrative expenses
-11.86%2.73M
-0.72%3.05M
-0.78%3.29M
-5.28%12.75M
-0.76%3.26M
-5.24%3.09M
-4.68%3.07M
-9.89%3.32M
16.06%13.46M
25.59%3.29M
-General and administrative expense
-11.86%2.73M
-0.72%3.05M
-0.78%3.29M
-5.28%12.75M
-0.76%3.26M
-5.24%3.09M
-4.68%3.07M
-9.89%3.32M
16.06%13.46M
25.59%3.29M
Research and development costs
-13.74%6.45M
0.53%6.61M
-32.91%6.06M
-9.78%29.75M
-24.19%6.67M
-11.45%7.48M
-24.93%6.58M
29.40%9.03M
36.93%32.98M
46.19%8.8M
Other operating expenses
-175.98%-494K
-655.66%-801K
-180.30%-569K
47.32%-785K
-73.68%-297K
53.14%-179K
44.50%-106K
72.79%-203K
65.47%-1.49M
69.24%-171K
Operating profit
16.45%-8.68M
7.15%-8.86M
27.70%-8.78M
7.19%-41.71M
19.13%-9.64M
8.26%-10.39M
19.08%-9.55M
-22.51%-12.14M
-43.30%-44.95M
-47.46%-11.92M
Net non-operating interest income expense
-58.90%217K
-47.50%304K
-40.40%391K
187.64%2.24M
-8.35%472K
164.00%528K
972.22%579K
8,100.00%656K
2,254.55%777K
7,257.14%515K
Non-operating interest income
-58.90%217K
-47.50%304K
-40.40%391K
187.64%2.24M
-8.35%472K
164.00%528K
972.22%579K
8,100.00%656K
2,254.55%777K
7,257.14%515K
Other net income (expense)
Income before tax
14.18%-8.46M
4.54%-8.56M
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
Income tax
Net income
14.18%-8.46M
4.54%-8.56M
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
Net income continuous Operations
14.18%-8.46M
4.54%-8.56M
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
Minority interest income
Net income attributable to the parent company
14.18%-8.46M
4.54%-8.56M
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.18%-8.46M
4.54%-8.56M
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
Basic earnings per share
14.63%-2.86
5.25%-2.89
27.99%-2.83
20.06%-13.43
22.25%-3.11
20.24%-3.35
33.70%-3.05
1.75%-3.93
-31.25%-16.8
-25.00%-4
Diluted earnings per share
14.63%-2.86
5.25%-2.89
27.99%-2.83
20.06%-13.43
22.25%-3.11
20.24%-3.35
33.70%-3.05
1.75%-3.93
-31.25%-16.8
-25.00%-4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -16.45%8.68M-7.15%8.86M-27.70%8.78M-7.19%41.71M-19.13%9.64M-8.26%10.39M-19.08%9.55M22.51%12.14M43.30%44.95M47.46%11.92M
Selling and administrative expenses -11.86%2.73M-0.72%3.05M-0.78%3.29M-5.28%12.75M-0.76%3.26M-5.24%3.09M-4.68%3.07M-9.89%3.32M16.06%13.46M25.59%3.29M
-General and administrative expense -11.86%2.73M-0.72%3.05M-0.78%3.29M-5.28%12.75M-0.76%3.26M-5.24%3.09M-4.68%3.07M-9.89%3.32M16.06%13.46M25.59%3.29M
Research and development costs -13.74%6.45M0.53%6.61M-32.91%6.06M-9.78%29.75M-24.19%6.67M-11.45%7.48M-24.93%6.58M29.40%9.03M36.93%32.98M46.19%8.8M
Other operating expenses -175.98%-494K-655.66%-801K-180.30%-569K47.32%-785K-73.68%-297K53.14%-179K44.50%-106K72.79%-203K65.47%-1.49M69.24%-171K
Operating profit 16.45%-8.68M7.15%-8.86M27.70%-8.78M7.19%-41.71M19.13%-9.64M8.26%-10.39M19.08%-9.55M-22.51%-12.14M-43.30%-44.95M-47.46%-11.92M
Net non-operating interest income expense -58.90%217K-47.50%304K-40.40%391K187.64%2.24M-8.35%472K164.00%528K972.22%579K8,100.00%656K2,254.55%777K7,257.14%515K
Non-operating interest income -58.90%217K-47.50%304K-40.40%391K187.64%2.24M-8.35%472K164.00%528K972.22%579K8,100.00%656K2,254.55%777K7,257.14%515K
Other net income (expense)
Income before tax 14.18%-8.46M4.54%-8.56M26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M
Income tax
Net income 14.18%-8.46M4.54%-8.56M26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M
Net income continuous Operations 14.18%-8.46M4.54%-8.56M26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M
Minority interest income
Net income attributable to the parent company 14.18%-8.46M4.54%-8.56M26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.18%-8.46M4.54%-8.56M26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M
Basic earnings per share 14.63%-2.865.25%-2.8927.99%-2.8320.06%-13.4322.25%-3.1120.24%-3.3533.70%-3.051.75%-3.93-31.25%-16.8-25.00%-4
Diluted earnings per share 14.63%-2.865.25%-2.8927.99%-2.8320.06%-13.4322.25%-3.1120.24%-3.3533.70%-3.051.75%-3.93-31.25%-16.8-25.00%-4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List